The treatment process of an extremely rare giant borderline phyllodes tumor of breast: case report and literature review

Giant phyllodes tumors are rare fibroepithelial neoplasms, usually defined as >10 cm. It is often difficult for pathologists to distinguish fibroadenomas from phyllodes tumors and determine the malignant potential level. The current treatment principle is to ensure the extended resection of tumors with a margin of 1 cm or more. For patients with multiple local recurrences or large tumors after surgery, simple mastectomy is recommended. Axillary management should be considered when breast cancer is diagnosed at the same time. We now present a rare case: a female patient found a right breast mass in 2014, and the mass had continued to grow for more than 7 months, and she was ultimately diagnosed with a giant phyllodes tumor with a diameter of 30 cm. Extensive resection is a suitable method to treat smaller phyllodes tumors, but giant phyllodes tumors require mastectomy, so the patient in this case underwent a total mastectomy. We removed the mass completely without destroying the normal tissue and structure. The treatment effect was obvious, and no related adverse events occurred during or after the operation, the postoperative recovery was good, and the patient was discharged once she was verified to be in a stable condition. This case is the first reported case of a patient who had a giant borderline phyllodes tumor with a diameter of 30 cm, underwent total mastectomy, and was followed up for 6 months without recurrence. The long-term effect of the treatment will be further evaluated after 5 years.

[1]  T. Chambers,et al.  The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study , 2019, Oncology letters.

[2]  A. Goldberg,et al.  Malignant Phyllodes Tumors of the Breast: Association Between Race, Clinical Features, and Outcomes. , 2019, The Journal of surgical research.

[3]  Y. Nie,et al.  Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis , 2019, BMC Cancer.

[4]  R. George,et al.  Phyllodes tumour of the breast and margins: How much is enough , 2019, Canadian journal of surgery. Journal canadien de chirurgie.

[5]  J. Mituś,et al.  Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre. , 2019, Breast.

[6]  E. Song,et al.  Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis , 2019, Annals of Surgical Oncology.

[7]  M. Vázquez Caruncho,et al.  Percutaneous removal of benign phyllodes tumor of the breast: An alternative to surgery , 2018, The breast journal.

[8]  T. Read,et al.  Diagnosing phyllodes tumours of the breast: how successful are our current preoperative assessment modalities? , 2018, ANZ journal of surgery.

[9]  N. Taib,et al.  Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women , 2018, Medicine.

[10]  H. Tsunoda,et al.  Repeat recurrence and malignant transition of phyllodes tumors of the breast , 2018, Breast Cancer.

[11]  M. Knowling,et al.  Phyllodes tumors of the breast: The British Columbia Cancer Agency experience. , 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[12]  Liying Zhang,et al.  A retrospective review of phyllodes tumours of the breast: A single institution experience. , 2018, Breast.

[13]  A. Sevinc,et al.  Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast? , 2018, Turkish journal of medical sciences.

[14]  K. Hess,et al.  Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. , 2018, AJR. American journal of roentgenology.

[15]  V. Yogi,et al.  Effect of postoperative time for adjuvant radiotherapy in malignant phyllodes tumor: An institutional experience , 2018, Journal of cancer research and therapeutics.

[16]  G. Tse,et al.  Mammary phyllodes tumour: a 15-year multicentre clinical review , 2017, Journal of Clinical Pathology.

[17]  A. Sanchez,et al.  Metastatic giant malignant phyllodes tumor of the breast , 2017, The breast journal.

[18]  B. Poirier,et al.  How Wide Should Margins Be for Phyllodes Tumors of the Breast? , 2017, The breast journal.

[19]  Kyubo Kim,et al.  Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data. , 2017, Breast.

[20]  T. George,et al.  Phyllodes tumors of the breast: Analysis of 35 cases from a single institution. , 2016, Journal of the Egyptian National Cancer Institute.

[21]  Yanhong Zhang,et al.  Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. , 2016, Archives of pathology & laboratory medicine.

[22]  P. Tan,et al.  Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience. , 2016, The Malaysian journal of pathology.

[23]  J. Madrid,et al.  Tumor Phyllodes de mama: Estudio clínico-patológico de 77 casos en una cohorte hispana. Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort , 2015 .

[24]  Selvamani,et al.  Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease—Analysis of 7 Cases , 2015, Indian Journal of Surgical Oncology.

[25]  V. Semiglazov,et al.  Diagnosis and treatment of phylloides tumors of the breast. , 2016, Voprosy onkologii.

[26]  T. Çolakoğlu,et al.  Comparison of predictive factors for the diagnosis and clinical course of phyllodes tumours of the breast. , 2015, Acta chirurgica Belgica.

[27]  M. Vilain,et al.  [Phyllodes tumors]. , 1995, Archives d'anatomie et de cytologie pathologiques.